How effective is the Lao generic version of giritinib? Comparative analysis with genuine products

Gilteritinib is a targeted drug for the treatment of FLT3 mutated acute myeloid leukemia (AML). It has been widely used around the world. Its original drug was developed by Japan's Astellas Company and has clear efficacy, but it is expensive and brings financial burden to many patients.

In recent years, countries such as Laos have gradually launched generic versions of giritinib. For example, Laos United Pharmaceuticals, ASEAN Pharmaceuticals, Lucius Pharmaceuticals, Daxiong Pharmaceuticals, etc. have all produced and marketed giritinib generic versions with a specification of 40 mg × 90 tablets. Each box sells for about 2,000 yuan, which is several times cheaper than the original drug, attracting the attention of many domestic patients. The preparation process, active ingredients, specifications and dosage of generic drugs are basically the same as those of the original drugs. Their efficacy is theoretically equivalent to that of the original drugs, and they can achieve similar blood concentration and clinical efficacy. Feedback from some patients taking the Laos generic version of giritinib also showed improvements in blood levels and good symptom control.

However, it should be noted that most of these generic drugs have not yet been approved by the China State Food and Drug Administration and are "overseas self-purchased" drugs. The quality control standards may be somewhat different from those of international original products, and there are risks such as batch stability and impurity control.

Therefore, patients should be extremely cautious when choosing the Lao version of giritinib. It is best to reasonably evaluate the risks and benefits of medication under the guidance of professional doctors to ensure efficacy while taking medication safety into consideration. For patients with limited financial conditions but urgent need for treatment, Laos' generic version of giritinib may be a feasible alternative, but it is still recommended to regularly monitor the efficacy and side effects, and never use it blindly for a long time on your own. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.

Reference materials:https://www.xospata.com/